Relay Therapeutics Inc.
RLAY | NASDAQ
$18.42
+$0.23 (+1.26%)
Sep 22, 2026, 12:32 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -5.25 | -1.75 | -3.95 | -5.77 | -8.04 | -16.23 |
PEG Ratio | 0.17 | 0.11 | -0.51 | 0.18 | -0.16 | 0.19 |
PS Ratio | 94.54 | 58.82 | 52.83 | 1.21K | 964.56 | 45.28 |
PB Ratio | 2.56 | 0.76 | 1.79 | 1.76 | 3.25 | 4.90 |
P/FCF Ratio | -6.15 | -2.34 | -4.43 | -7.03 | -37.52 | -35.84 |
P/OCF Ratio | -6.17 | -2.36 | -4.49 | -7.31 | -39.27 | -36.52 |
OCF/S Ratio | -1.53K | -2.49K | -1.18K | -16.62K | -2.46K | -124 |
Debt / Equity Ratio | 0.06 | 0.06 | 0.07 | 0.06 | 0.03 | 0.03 |
Quick Ratio | 22.61 | 15.95 | 25.44 | 15.81 | 40.14 | 56.49 |
Current Ratio | 22.61 | 15.95 | 25.44 | 16 | 40.14 | 56.49 |
Asset Turnover | 0.02 | 0.01 | 0.03 | 0 | 0 | 0.10 |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -48.76% | -43.42% | -45.48% | -30.57% | -40.53% | -6.87% |
Return on Assets | -44.50% | -38.76% | -40.52% | -26.42% | -36.08% | -6.55% |
Return on Invested Capital | -50.50% | -45.08% | -45.56% | -28.77% | -36.99% | -7.08% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 76.83% | -3.05K% | -1.18K% | -17.5K% | -5.49K% | 95.71% |
Net Profit Margin | -1.8K% | -3.37K% | -1.34K% | -21.04K% | -12.01K% | -63.41% |
Pretax Profit Margin | -1.8K% | -3.37K% | -1.34K% | -21.04K% | -12.01K% | -63.41% |
Operating Profit Margin | -1.97K% | -3.72K% | -1.46K% | -21.67K% | -12.04K% | -67.51% |
FCF Margin | -1.54K% | -2.51K% | -1.19K% | -17.27K% | -2.57K% | -126.33% |
EBITDA Margin | -1.78K% | -3.8K% | -1.46K% | -22.22K% | -7.36K% | -63.21% |
Add to Watchlist
Select watchlists to add or remove RLAY